Inventor · disambiguated record
Christopher R. Young
Also filed as: YOUNG CHRISTOPHER · YOUNG CHRISTOPHER R · YOUNG CHRISTOPHER RYAN
18 granted patents·20 pending applications·1,022 citations·filing 2004–2022
97Inventor score
Top patents by PatentIndex Score
38 records- 0198US9670163B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2015·Granted Jun 6, 2017·44 cites·8 claims
- 0298US9139530B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2014·Granted Sep 22, 2015·64 cites·28 claims
- 0398US8754224B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2013·Granted Jun 17, 2014·97 cites·18 claims
- 0497US10646481B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2016·Granted May 12, 2020·21 cites·26 claims
- 0597US10537565B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2018·Granted Jan 21, 2020·24 cites·26 claims
- 0697US9931334B2Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2017·Granted Apr 3, 2018·35 cites·17 claims
- 0797US9241934B2Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereofVERTEX PHARMA·Filed 2014·Granted Jan 26, 2016·58 cites·37 claims
- 0897US9192606B2Dosage units of 3-(6-(1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidVERTEX PHARMA·Filed 2014·Granted Nov 24, 2015·50 cites·58 claims
- 0996US11564916B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2020·Granted Jan 31, 2023·7 cites·40 claims
- 1096US10076513B2Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereofVERTEX PHARMA·Filed 2016·Granted Sep 18, 2018·27 cites·49 claims
- 1196US8716338B2Dosage units of 3-(6-(1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidYOUNG CHRISTOPHER·Filed 2009·Granted May 6, 2014·71 cites·58 claims
- 1296US8410274B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideHURTER PATRICIA·Filed 2012·Granted Apr 2, 2013·109 cites·22 claims
- 1396US7553855B2Compositions of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2007·Granted Jun 30, 2009·186 cites·24 claims
- 1495US11052075B2Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereofVERTEX PHARMA·Filed 2019·Granted Jul 6, 2021·13 cites·22 claims
- 1595US8552034B2Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereofVERWIJS MARINUS JACOBUS·Filed 2011·Granted Oct 8, 2013·98 cites·55 claims
- 1694US8076357B2Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideYOUNG CHRISTOPHER R·Filed 2009·Granted Dec 13, 2011·113 cites·3 claims
- 1792US11291662B2Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2019·Granted Apr 5, 2022·5 cites·4 claims
- 1884US2023263794A1Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 1977US2022031679A1Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereofVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2066US2019070155A1Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereofVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 2166US2010074949A1Pharmaceutical composition and administration thereofROWE WILLIAM·Filed 2009·Application pending·0 cites
- 2265US12458635B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2022·Granted Nov 4, 2025·0 cites·17 claims
- 2363US2014023706A1Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereofVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2461US2011064811A1Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideHURTER PATRICIA·Filed 2006·Application pending·0 cites
- 2561US2013095181A1Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 2659US2014112988A1Pharmaceutical Composition and Administrations ThereofVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2758US2013158071A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 2857US2014315948A1Pharmaceutical Composition and Administrations ThereofVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2957US2013131107A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 3052US2016022665A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 3152US2006251724A1Method for preparing thermoformed compositions containing acrylic polymer binders, pharmaceutical dosage forms and methods of preparing the sameFARRELL THOMAS P·Filed 2004·Application pending·0 cites
- 3252US2012258983A1Pharmaceutical Composition and Administrations ThereofROWE WILLIAM·Filed 2012·Application pending·0 cites
- 3351US2016022664A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 3450US2009176839A1Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidKESHAVARZ-SHOKRI ALI·Filed 2008·Application pending·0 cites
- 3549US2016039800A1Dosage units of 3-(6-(1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 3648US2012122922A1Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideYOUNG CHRISTOPHER R·Filed 2011·Application pending·0 cites
- 3747US2010256184A1Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2010·Application pending·0 cites
- 3839US2012220625A1Pharmaceutical composition and administrations thereofROWE WILLIAM·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher R. Young files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →